We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Epidural steroid injections: an updated review on recent trends in safety and complications

    Mark C Bicket

    Department of Anesthesiology, Critical Care & Pain Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA

    ,
    Krishnan Chakravarthy

    Department of Anesthesiology & Critical Care Medicine, Johns Hopkins Pain Treatment Center, 550 North Broadway, Suite 301, Baltimore, MD 21205, USA

    ,
    David Chang

    Department of Anesthesiology & Critical Care Medicine, Johns Hopkins Pain Treatment Center, 550 North Broadway, Suite 301, Baltimore, MD 21205, USA

    &
    Steven P Cohen

    *Author for correspondence:

    E-mail Address: scohen40@jhmi.edu

    Department of Anesthesiology & Critical Care Medicine, Johns Hopkins Pain Treatment Center, 550 North Broadway, Suite 301, Baltimore, MD 21205, USA

    Department of Physical Medicine & Rehabilitation, Johns Hopkins School of Medicine, 707 North Broadway, Baltimore, MD 21205, USA

    Published Online:https://doi.org/10.2217/pmt.14.53

    SUMMARY 

    Epidural steroid injections (ESIs), which can provide significant but temporary pain relief in well-selected patients, are the most commonly performed procedure in pain management. The anatomy of the epidural space provides a framework for understanding risks associated with ESIs, a topic relevant to both patients and physicians in interventional pain, surgery and primary care. Safety considerations of epidural steroids include drug preparation and myriad physiological effects stemming from steroid exposure. Although major complications associated with ESI occur rarely, potentially catastrophic events resulting from infectious, hematologic and neurologic morbidity may lead to permanent injury. The safety profile of ESIs may improve with development and dissemination of sound injection technique, safer compounds manufactured in a sterile manner and deficient of thromboembolic potential and the application of existing technology.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest:

    References

    • 1 Hoy D, March L, Brooks P et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann. Rheum. Dis. 73(6), 968–974 (2014).
    • 2 Hoy D, March L, Woolf A et al. The global burden of neck pain: estimates from the global burden of disease 2010 study. Ann. Rheum. Dis. 73(7), 1309–1315 (2014).
    • 3 Martin BI, Deyo RA, Mirza SK et al. Expenditures and health status among adults with back and neck problems. JAMA 299(6), 656–664 (2008).
    • 4 Hoy D, Bain C, Williams G et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 64(6), 2028–2037 (2012).
    • 5 Fejer R, Kyvik KO, Hartvigsen J. The prevalence of neck pain in the world population: a systematic critical review of the literature. Eur. Spine J. 15(6), 834–848 (2006).
    • 6 Hogg-Johnson S, van der Velde G, Carroll LJ et al. The burden and determinants of neck pain in the general population: results of the Bone and Joint Decade 2000–2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila. Pa. 1976) 33(4 Suppl.), S39–S51 (2008).
    • 7 da C, Menezes Costa L, Maher CG, Hancock MJ, McAuley JH, Herbert RD, Costa LO. The prognosis of acute and persistent low-back pain: a meta-analysis. CMAJ 184(11), E613–E624 (2012).
    • 8 Vasseljen O, Woodhouse A, Bjørngaard JH, Leivseth L. Natural course of acute neck and low back pain in the general population: the HUNT study. Pain 154(8), 1237–1244 (2013).
    • 9 Vos CJ, Verhagen AP, Passchier J, Koes BW. Clinical course and prognostic factors in acute neck pain: an inception cohort study in general practice. Pain Med. 9(5), 572–580 (2008).
    • 10 Cohen, SP. Epidemiology, diagnosis and treatment of neck pain. Mayo Clin. Proc. (2014)(In Press).
    • 11 Beith ID, Kemp A, Kenyon J, Prout M, Chestnut TJ. Identifying neuropathic back and leg pain: a cross-sectional study. Pain 152(7), 1511–1516 (2011).
    • 12 El Sissi W, Arnaout A, Chaarani MW et al. Prevalence of neuropathic pain among patients with chronic low-back pain in the Arabian Gulf Region assessed using the leeds assessment of neuropathic symptoms and signs pain scale. J. Int. Med. Res. 38(6), 2135–2145 (2010).
    • 13 Salemi G, Savettieri G, Meneghini F et al. Prevalence of cervical spondylotic radiculopathy: a door-to-door survey in a Sicilian municipality. Acta Neurol. Scand. 93(2–3), 184–188 (1996).
    • 14 Schoenfeld AJ, George AA, Bader JO et al. Incidence and epidemiology of cervical radiculopathy in the United States military: 2000 to 2009. J. Spinal Disord. Tech. 25(1), 17–22 (2012).
    • 15 Radhakrishnan K, Litchy WJ, O'Fallon WM et al. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain 117(Pt 2), 325–335 (1994).
    • 16 Kleinman N, Patel AA, Benson C, Macario A, Kim M, Biondi DM. Economic burden of back and neck pain: effect of a neuropathic component. Popul. Health Manag. 17(4), 224–232 (2014).
    • 17 Mehra M, Hill K, Nicholl D, Schadrack J. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. J. Med. Econ. 15(2), 245–252 (2012).
    • 18 Manchikanti L, Pampati V, Falco FJ, Hirsch JA. Growth of spinal interventional pain management techniques: analysis of utilization trends and Medicare expenditures 2000 to 2008. Spine (Phila. Pa. 1976) 38(2), 157–168 (2013).• The substantial increase in interventional pain procedures is described in this review of Medicare expenditures.
    • 19 Hoeft MA, Rathmell JP, Monsey RD, Fonda BJ. Cervical transforaminal injection and the radicular artery: variation in anatomical location within the cervical intervertebral foramina. Reg. Anesth. Pain Med. 31(3), 270–274 (2006).
    • 20 Nijenhuis RJ, Leiner T, Cornips EM et al. Spinal cord feeding arteries at MR angiography for thoracoscopic spinal surgery: feasibility study and implications for surgical approach. Radiology 233(2), 541–547 (2004).
    • 21 Houten JK, Errico TJ. Paraplegia after lumbosacral nerve root block: report of three cases. Spine J. 2(1), 70–75 (2002).
    • 22 MacLean CA, Bachman DT. Documented arterial gas embolism after spinal epidural injection. Ann. Emerg. Med. 38(5), 592–595 (2001).
    • 23 Aldrete JA, Mushin AU, Zapata JC, Ghaly R. Skin to cervical epidural space distances as read from magnetic resonance imaging films: consideration of the “hump pad.” J. Clin. Anesth. 10(4), 309–313 (1998).
    • 24 Moon JY, Lee PB, Nahm FS, Kim YC, Choi JB. Cervical epidural pressure measurement: comparison in the prone and sitting positions. Anesthesiology 113(3), 666–671 (2010).
    • 25 Gil NS, Lee JH, Yoon SZ, Jeon Y, Lim YJ, Bahk JH. Comparison of thoracic epidural pressure in the sitting and lateral decubitus positions. Anesthesiology 109(1), 67–71 (2008).
    • 26 Stojanovic MP, Vu TN, Caneris O, Slezak J, Cohen SP, Sang CN. The role of fluoroscopy in cervical epidural steroid injections: an analysis of contrast dispersal patterns. Spine (Phila. Pa. 1976) 27(5), 509–514 (2002).
    • 27 Liu SS, Melmed AP, Klos JW, Innis CA. Prospective experience with a 20-gauge Tuohy needle for lumbar epidural steroid injections: is confirmation with fluoroscopy necessary? Reg. Anesth. Pain Med. 26(2), 143–146 (2001).
    • 28 Barham G, Hilton A. Caudal epidurals: the accuracy of blind needle placement and the value of a confirmatory epidurogram. Eur. Spine J. 19(9), 1479–83 (2010).
    • 29 Stitz MY, Sommer HM. Accuracy of blind versus fluoroscopically guided caudal epidural injection. Spine (Phila. Pa. 1976) 24(13), 1371–1376 (1999).
    • 30 Benzon HT, Chew TL, McCarthy RJ, Benzon HA, Walega DR. Comparison of the particle sizes of different steroids and the effect of dilution: a review of the relative neurotoxicities of the steroids. Anesthesiology 106(2), 331–338 (2007).• Differences in particulate and nonparticulate steroids were firmly established with publication of this examination of steroid particle sizes.
    • 31 Derby R, Lee SH, Date ES, Lee JH, Lee CH. Size and aggregation of corticosteroids used for epidural injections. Pain Med. 9(2), 227–234 (2008).
    • 32 Dreyfuss P, Baker R, Bogduk N. Comparative effectiveness of cervical transforaminal injections with particulate and nonparticulate corticosteroid preparations for cervical radicular pain. Pain Med. 7(3), 237–242 (2006).
    • 33 Park CH, Lee SH, Kim BI. Comparison of the effectiveness of lumbar transforaminal epidural injection with particulate and nonparticulate corticosteroids in lumbar radiating pain. Pain Med. 11(11), 1654–1658 (2010).
    • 34 Kim D, Brown J. Efficacy and safety of lumbar epidural dexamethasone versus methylprednisolone in the treatment of lumbar radiculopathy: a comparison of soluble versus particulate steroids. Clin. J. Pain 27(6), 518–522 (2011).
    • 35 Datta R, Upadhyay BK. A randomized clinical trial of three difference steroid agents for treatment of low backache through the caudal route. Armed Forces Med. J. India 67(1), 25–33 (2011).
    • 36 Drazen JM, Curfman GD, Baden LR, Morrissey S. Compounding errors. N. Engl. J. Med. 367(25), 2436–2437 (2012).
    • 37 Benzon HT. Compounded steroids for epidural injections: what are the issues? Anesth. Analg. 117(2), 523–526 (2013).
    • 38 Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy. Morb. Mortal. Wkly Rep. 51(49), 1109–1112 (2002).
    • 39 Kainer MA, Reagan DR, Nguyen DB et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. N. Engl. J. Med. 367(23), 2194–2203 (2012).•• Preliminary results from the 2012–2013 outbreak of fungal meningitis detail the consequences of injecting steroids that were contaminated by compounding pharmacies.
    • 40 Outterson K. Regulating compounding pharmacies after NECC. N. Engl. J. Med. 367(21), 1969–1972 (2012).
    • 41 De Vries F, Bracke M, Leufkens HGM et al. Fracture risk with intermittent high dose oral glucocorticoid therapy. Arthritis Rheum. 56(1), 208–214 (2007).
    • 42 Mitra R. Adverse effects of corticosteroids on bone metabolism: a review. PMR 3(5), 466–471 (2011).
    • 43 Steinbuch M, Youket TE, Cohen S. Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int. 15(4), 323–328 (2004).
    • 44 Al-Shoha A, Rao DS, Schilling J, Peterson E, Mandel S. Effect of epidural steroid injection on bone mineral density and markers of bone turnover in postmenopausal women. Spine (Phila. Pa. 1976) 37(25), E1567–E1571 (2012).
    • 45 Kim S, Hwang B. Relationship between bone mineral density and the frequent administration of epidural steroid injections in postmenopausal women with low back pain. Pain Res. Manag. 19(1), 30–34 (2014).
    • 46 Kang SS, Hwang BM, Son H, Cheong IY, Lee SJ, Chung TY. Changes in bone mineral density in postmenopausal women treated with epidural steroid injections for lower back pain. Pain Physician 15(3), 229–236 (2012).
    • 47 Yi Y, Hwang B, Son H, Cheong IY. Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain. Pain Physician 15(6), 441–449 (2012).
    • 48 Mandel S, Schilling J, Peterson E, Rao DS, Sanders W. A retrospective analysis of vertebral body fractures following epidural steroid injections. J. Bone Joint Surg. Am. 95(11), 961–964 (2013).
    • 49 Friedly JL, Comstock BA, Turner JA et al. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N. Engl. J. Med. 371(1), 11–21 (2014).
    • 50 Lansang MC, Farmer T, Kennedy L. Diagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injections. Endocr. Pract. 15(3), 225–228 (2009).
    • 51 Tuel SM, Meythaler JM, Cross LL. Cushing's syndrome from epidural methylprednisolone. Pain 40(1), 81–84 (1990).
    • 52 Horani MH, Silverberg AB. Secondary Cushing's syndrome after a single epidural injection of a corticosteroid. Endocr. Pract. 11(6), 408–410 (2005).
    • 53 Fessler D, Beach J, Keel J, Stead W. Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors. Pain Physician 15(6), 489–493 (2012).
    • 54 Sadarangani S, Berg ML, Mauck W, Rizza S. Iatrogenic cushing syndrome secondary to ritonavir-epidural triamcinolone interaction: an illustrative case and review. Interdiscip. Perspect. Infect. Dis. 849432 (2014).
    • 55 Kay J, Findling JW, Raff H. Epidural triamcinolone suppresses the pituitary-adrenal axis in human subjects. Anesth. Analg. 79(3), 501–505 (1994).
    • 56 Leary J, Swislocki A. Hypothalamic-pituitary-adrenal suppression and iatrogenic cushing's syndrome as a complication of epidural steroid injections. Case Rep. Endocrinol. 2013, 617042 (2013).
    • 57 Gensler LS. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist 3(2), 92–97 (2013).
    • 58 Hooten WM, Mizerak A, Carns PE, Huntoon MA. Discitis after lumbar epidural corticosteroid injection: a case report and analysis of the case report literature. Pain Med. 7(1), 46–51 (2006).
    • 59 Cansever T, Kabatas S, Civelek et al. Transforaminal epidural steroid injection via a preganglionic approach for the treatment of lumbar radicular pain. Turk. Neurosurg. 22(2), 183–188 (2012).
    • 60 Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 42, RR-4 (1993).
    • 61 Even JL, Crosby CG, Song Y et al. Effects of epidural steroid injections on blood glucose levels in patients with diabetes mellitus. Spine (Phila. Pa. 1976) 37(1), E46–E50 (2012).
    • 62 Gonzalez P, Laker SR, Sullivan W, Harwood JE, Akuthota V. The effects of epidural betamethasone on blood glucose in patients with diabetes mellitus. PMR 1(4), 340–345 (2009).
    • 63 Younes M, Neffati F, Touzi M et al. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Joint Bone Spine 74(5), 472–476 (2007).
    • 64 Kim WH, Sim WS, Shin BS et al. Effects of two different doses of epidural steroid on blood glucose levels and pain control in patients with diabetes mellitus. Pain Physician 16(6), 557–568 (2013).
    • 65 Trentman TL, Rosenfeld DM, Seamans DP, Hentz JG, Stanek JP. Vasovagal reactions and other complications of cervical vs. lumbar translaminar epidural steroid injections. Pain Pract. 9(1), 59–64 (2009).
    • 66 Kennedy DJ, Schneider B, Casey E et al. Vasovagal rates in flouroscopically guided interventional procedures: a study of over 8,000 injections. Pain Med. 14(12), 1854–1859 (2013).
    • 67 Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Fellows B. A prospective evaluation of complications of 10,000 fluoroscopically directed epidural injections. Pain Physician 15(2), 131–140 (2012).
    • 68 Davignon KR, Dennehy KC. Update on postdural puncture headache. Int. Anesthesiol. Clin. 40(4), 89–102 (2002).
    • 69 Cohen SP, Bicket MC, Jamison D, Wilkinson I, Rathmell JP. Epidural steroids: a comprehensive, evidence-based review. Reg. Anesth. Pain Med. 38(3), 175–200 (2013).•• This evidence-based review systematically provides a thorough examination of the literature related to epidural steroid injections, with a particular emphasis on the influence of approach and region of epidural steroid delivery, the type and dose of injectate and factors associated with treatment success.
    • 70 Verdun AV, Cohen SP, Williams BS et al. Pneumocephalus after lumbar epidural steroid injection: a case report and review of the literature. Anesth. Analg. Case Reports 3(1), 9–13 (2014).
    • 71 Sweni S, Senthilkumaran S, Balamurugan N, Thirumalaikolundusubramanian P. Tension pneumocephalus: a case report with review of literature. Emerg. Radiol. 20(6), 573–578 (2013).
    • 72 McGrath JM, Schaefer MP, Malkamaki DM. Incidence and characteristics of complications from epidural steroid injections. Pain Med. 12(5), 726–731 (2011).
    • 73 Everett CR, Baskin MN, Speech D, Novoseletsky D, Patel R. Flushing as a side effect following lumbar transforaminal epidural steroid injection. Pain Physician 7(4), 427–429 (2004).
    • 74 Abbasi A, Roque-Dang CM, Malhotra G. Persistent hiccups after interventional pain procedures: a case series and review. PMR 4(2), 144–151 (2012).
    • 75 Özcan U, Şahin Ş, Gurbet A, Türker G, Özgür M, Çelebi S. Comparison of blunt and sharp needles for transforaminal epidural steroid injections. Agri 24(2), 85–89 (2012).
    • 76 Candido KD, Katz JA, Chinthagada M, McCarthy RA, Knezevic NN. Incidence of intradiscal injection during lumbar fluoroscopically guided transforaminal and interlaminar epidural steroid injections. Anesth. Analg. 110(5), 1464–1467 (2010).
    • 77 Plastaras CT, Casey E, Goodman BS, Chou L, Roth D, Rittenberg J. Inadvertent intradiscal contrast flow during lumbar transforaminal epidural steroid injections: a case series examining the prevalence of intradiscal injection as well as potential associated factors and adverse events. Pain Med. 11(12), 1765–1773 (2010).
    • 78 Hong JH, Lee SM, Bae JH. Analysis of inadvertent intradiscal injections during lumbar transforaminal epidural injection. Korean J. Pain 27(2), 168–173 (2014).
    • 79 Banerjee AK, Okun S, Edwards IR et al. Patient-reported outcome measures in safety event reporting: PROSPER Consortium guidance. Drug Saf. 36(12), 1129–1149 (2013).
    • 80 Baker R, Dreyfuss P, Mercer S, Bogduk N. Cervical transforaminal injection of corticosteroids into a radicular artery: a possible mechanism for spinal cord injury. Pain 103(1–2), 211–215 (2003).
    • 81 Wald JT, Maus TP, Deske JR et al. Safety and efficacy of CT-guided transforaminal cervical epidural steroid injections using a posterior approach. AJNR Am. J. Neuroradiol.. 33(3), 415–419 (2012).
    • 82 Cohen SP, Maine DN, Shockey SM, Kudchadkar S, Griffith S. Inadvertent disk injection during transforaminal epidural steroid injection: steps for prevention and management. Pain Med. 9(6), 688–694 (2008).
    • 83 Lejeune JP, Hladky JP, Cotten A, Vinchon M, Christiaens JL. Foraminal lumbar disc herniation. Experience with 83 patients. Spine (Phila Pa 1976) 19(17), 1905–1908 (1994).
    • 84 Centers for Disease Control and Prevention. Multistate fungal meningitis outbreak investigation. www.cdc.gov/hai/outbreaks/meningitis-map-large.html.
    • 85 Chiller TM, Roy M, Nguyen D et al. Clinical findings for fungal infections caused by methylprednisolone injections. N. Engl. J. Med. 369(17), 1610–1619 (2013).• The early clinical outcomes of the patients exposed to contaminated steroid products through spinal injections are described.
    • 86 Fitzgibbon DR, Posner KL, Domino KB, Caplan RA, Lee LA, Cheney FW. Chronic pain management: American Society of Anesthesiologists Closed Claims Project. Anesthesiology 100(1), 98–105 (2004).• Complications associated with epidural steroid injections accounted for 40% of all chronic pain management claims in the ASA Closed Claims Project.
    • 87 Tang HJ, Lin HJ, Liu YC, Li CM. Spinal epidural abscess-experience with 46 patients and evaluation of prognostic factors. J. Infect. 45(2), 76–81 (2002).
    • 88 Hooten WM, Mizerak A, Carns PE, Huntoon MA. Discitis after lumbar epidural corticosteroid injection: a case report and analysis of the case report literature. Pain Med. 7(1), 46–51 (2006).
    • 89 Davis K, Prater A, Fluker SA, Klein R. A difficult case to swallow: herpes esophagitis after epidural steroid injection. Am. J. Ther. 21(1), e9–e14 (2014).
    • 90 Wilkinson I, Cohen SP. Epidural steroids for spinal pain and radiculopathy: a narrative, evidence-based review. Curr. Opin. Anaesthesiol. 26(5), 562–572 (2013).
    • 91 Stoll A, Sanchez M. Epidural hematoma after epidural block: implications for its use in pain management. Surg. Neurol. 57(4), 235–240 (2002).
    • 92 Horlocker TT, Wedel DJ, Rowlingson JC et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines. Reg. Anesth. Pain Med. 35(1), 64–101 (2010).
    • 93 Horlocker TT. Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy. Br. J. Anaesth. 107(Suppl. 1), i96–i106 (2011).
    • 94 Rathmell J, Michna E, Fitzgibbon D et al. Injury and liability associated with cervical procedures for chronic pain. Anesthesiology 114(4), 918–926 (2011).
    • 95 Xu R, Bydon M, Gokaslan ZL, Wolinsky JP, Witham TF, Bydon A. Epidural steroid injection resulting in epidural hematoma in a patient despite strict adherence to anticoagulation guidelines. J. Neurosurg. Spine 11(3), 358–364 (2009).
    • 96 Manchikanti L, Benyamin R, Swicegood J et al. Assessment of practice patterns of perioperative management of antiplatelet and anticoagulant therapy in interventional pain management. Pain Physician 15(6), E955–E968 (2012).
    • 97 Epstein NE. The risks of epidural and transforaminal steroid injections in the spine: commentary and a comprehensive review of the literature. Surg. Neurol. Int. 4(Suppl. 2), S74–S93 (2013).
    • 98 Scanlon GC, Moeller-Bertram T, Romanowsky SM et al. Cervical transforaminal epidural steroid injections. More dangerous than we think? Spine (Phila. Pa. 1976) 32(11), 1249–1256 (2007).
    • 99 Atluri S, Glaser SE, Shah RV, Sudarshan G. Needle position analysis in cases of paralysis from transforaminal epidurals: consider alternative approaches to traditional technique. Pain Physician 16(4), 321–34 (2013).
    • 100 Glaser SE, Falco F. Paraplegia following a thoracolumbar transforaminal epidural steroid injection. Pain Physician 8(3), 309–14 (2005).
    • 101 Ludwig MA, Burns SP. Spinal cord infarction following cervical transforaminal epidural injection: a case report. Spine (Phila. Pa. 1976) 30(10), E266–E268 (2005).
    • 102 Food and Drug Adminstration. FDA Briefing Information for the November 24–25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee. www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm422691.htm.
    • 103 McMillan MR, Crumpton C. Cortical blindness and neurologic injury complicating cervical transforaminal injection for cervical radiculopathy. Anesthesiology 99(2), 509–511 (2003).
    • 104 Tiso RL, Cutler T, Catania JA et al. Adverse central nervous system sequelae after selective transforaminal block: the role of corticosteroids. Spine J. 4(4), 468–474 (2004).
    • 105 Windsor RE, Storm S, Sugar R et al. Cervical transforaminal injection: review of the literature, complications, and a suggested technique. Pain Physician 6(4), 457–465 (2003).
    • 106 Beckman WA, Mendez RJ, Paine GF et al. Cerebellar herniation after cervical transforaminal epidural injection. Reg. Anesth. Pain Med. 31(3), 282–285 (2006).
    • 107 Ziai WC, Ardelt AA, Llinas RH. Brainstem stroke following uncomplicated cervical epidural steroid injection. Arch. Neurol. 63(11), 1643–1646 (2006).
    • 108 Muro K, O'Shaughnessy B, Ganju A. Infarction of the cervical spinal cord following multilevel transforaminal epidural steroid injection: case report and review of the literature. J. Spinal Cord Med. 30(4), 385–388 (2007).
    • 109 Rozin L, Rozin R, Koehler SA et al. Death during transforaminal epidural steroid nerve root block (C7) due to perforation of the left vertebral artery. Am. J. Forensic Med. Pathol. 24(4), 351–355 (2003).
    • 110 Wallace MA, Fukui MB, Williams RL et al. Complications of cervical selective nerve root blocks performed with fluoroscopic guidance. AJR Am. J. Roentgenol. 188(5), 1218–1221 (2007).
    • 111 Okubadejo GO, Talcott MR, Schmidt RE et al. Perils of intravascular methylprednisolone injection into the vertebral artery. An animal study. J. Bone Joint Surg. Am. 90(9), 1932–1938 (2008).
    • 112 Dawley JD, Moeller-Bertram T, Wallace MS, Patel PM. Intra-arterial injection in the rat brain: evaluation of steroids used for transforaminal epidurals. Spine (Phila. Pa. 1976) 34(16), 1638–1643 (2009).
    • 113 Kraemer J, Ludwig J, Bickert U, Owczarek V, Traupe M. Lumbar epidural perineural injection: a new technique. Eur. Spine J. 6(5), 357–61 (1997).
    • 114 Furman MB, Giovanniello MT, O'Brien EM. Incidence of intravascular penetration in transforaminal cervical epidural steroid injections. Spine (Phila. Pa. 1976) 28(1), 21–25 (2003).
    • 115 Hong JH, Huh B, Shin HH. Comparison between digital subtraction angiography and real-time fluoroscopy to detect intravascular injection during lumbar transforaminal epidural injections. Reg. Anesth. Pain Med. 39(4), 329–332 (2014).
    • 116 El Abd OH, Amadera JE, Pimentel DC, Pimentel TS. Intravascular flow detection during transforaminal epidural injections: a prospective assessment. Pain Physician 17(1), 21–27 (2014).
    • 117 Kozlov N, Benzon HT, Malik K. Epidural steroid injections: update on efficacy, safety, and newer medications for injection. Minerva Anestesiol. (2014) (Epub ahead of print).
    • 118 Wybier M, Gaudart S, Petrover D, Houdart E, Laredo JD. Paraplegia complicating selective steroid injections of the lumbar spine. Report of five cases and review of the literature. Eur. Radiol. 20(1), 181–189 (2010).
    • 119 Chang Chien GC, Candido KD, Knezevic NN. Digital subtraction angiography does not reliably prevent paraplegia associated with lumbar transforaminal epidural steroid injection. Pain Physician 15(6), 515–523 (2012).
    • 120 Hodges SD, Castleberg RL, Miller T et al. Cervical epidural steroid injection with intrinsic spinal cord damage. Two case reports. Spine (Phila. Pa. 1976). 23(19), 2137–2142 (1998).
    • 121 Lee JH, Lee JK, Seo BR, Moon SJ, Kim JH, Kim SH. Spinal cord injury produced by direct damage during cervical transforaminal epidural injection. Reg. Anesth. Pain Med. 33(4), 377–379 (2008).
    • 122 Benzon HT, Wong HY, Siddiqui T, Ondra S. Caution in performing epidural injections in patients on several antiplatelet drugs. Anesthesiology 91(5), 1558–1559 (1999).
    • 123 Abram SE, Hogan QH. Avoiding catastrophic complications from epidural steroid injections. APSF Newsletter 26(1), 8–9 (2011).
    • 124 Stojanovic MP, Vu TN, Caneris O, Slezak J, Cohen SP, Sang CN. The role of fluoroscopy in cervical epidural steroid injections: an analysis of contrast dispersal patterns. Spine (Phila. Pa. 1976) 27(5), 509–514 (2002).
    • 125 Goel A, Pollan JJ. Contrast flow characteristics in the cervical epidural space: an analysis of cervical epidurograms. Spine (Phila. Pa. 1976) 31(14), 1576–1579 (2006).
    • 126 Rathmell JP, Benzon HT, Dreyfuss P et al. Safeguards to prevent neurologic complications after epidural steroid injections: recommendations from a multidisciplinary working group and national organizations. Anesthesiology doi:10.1097/ALN.0000000000000614 (2015) (Epub ahead of print).•• An expert multi-disciplinary working group and 13 stakeholder societies reviewed evidence and provided 17 recommendations for improving safety for transforaminal and interlaminar epidural injections.
    • 127 Aldrete JA. Chronic adhesive arachnoiditis. Br. J. Anaesth. 93(2), 301–307 (2004).
    • 128 Lima RM, Navarro LH, Carness JM et al. Clinical and histological effects of the intrathecal administration of methylprednisolone in dogs. Pain Physician 13(5), 493–501 (2010).
    • 129 Nanjayan SK, Swamy GN, Yallappa S, Bommireddy R. Arachnoiditis following caudal epidural injections for the lumbo-sacral radicular pain. Asian Spine J. 7(4), 355–358 (2013).
    • 130 Na EH, Han SJ, Kim MH. Delayed occurrence of spinal arachnoiditis following a caudal block. J. Spinal Cord Med. 34(6), 616–619 (2011).
    • 131 Young WF. Transient blindness after lumbar epidural steroid injection: a case report and literature review. Spine J. 27(21), E476–E477 (2002).
    • 132 Kim W, Kim JS, Lim SC, Kim YI, Moon DE. Reversible posterior leukoencephalopathy syndrome after cervical transforaminal epidural steroid injection presenting as transient blindness. Anesth. Analg. 112(4), 967–970 (2011).
    • 133 Browning DJ. Acute retinal necrosis following epidural steroid injections. Am. J. Ophthalmol. 136(1), 192–194 (2003).
    • 134 Pizzimenti JJ, Daniel KP. Central serous chorioretinopathy after epidural steroid injection. Pharmacotherapy 25(8), 1141–1146 (2005).
    • 135 Lee SB, Kim JY, Kim WJ, Cho CB, Iwase T, Jo YJ. Bilateral central serous chorioretinopathy with retinal pigment epithelium tears following epidural steroid injection. Indian J. Ophthalmol. 61(9), 514–515 (2013).
    • 136 Hodges SD, Castleberg RL, Miller T et al. Cervical epidural steroid injection with intrinsic spinal cord damage. Two case reports. Spine 23(19), 2137–2142 (1998).
    • 137 Abram SE, Francis MC. Hazards of sedation for interventional pain procedures. APSF Newsletter 27(2), 29–31 (2012).
    • 138 Shin J, Kim YC, Lee SC, Kim JH. A comparison of Quincke and Whitacre needles with respect to risk of intravascular uptake in S1 transforaminal epidural steroid injections: a randomized trial of 1376 cases. Anesth. Analg. 117(5), 1241–1247 (2013).
    • 139 Smuck M, Yu AJ, Tang CT, Zemper E. Influence of needle type on the incidence of intravascular injection during transforaminal epidural injections: a comparison of short-bevel and long-bevel needles. Spine J. 10(5), 367–371 (2010).
    • 140 Nishio I. Cervical transforaminal epidural steroid injections: a proposal for optimizing the preprocedural evaluation with available imaging. Reg. Anesth. Pain Med. 39(6), 546–9 (2014).
    • 141 Fitzgerald RT, Bartynski WS, Collins HR. Vertebral artery position in the setting of cervical degenerative disease: implications for selective cervical transforaminal epidural injections. Interv. Neuroradiol. 19(4), 425–31 (2013).
    • 142 Karasek M, Bogduk N. Temporary neurologic deficit after cervical transforaminal injection of local anesthetic. Pain Med. 5(2), 202–205 (2004).
    • 143 Owlia MB, Salimzadeh A, Alishiri G, Haghighi A. Comparison of two doses of corticosteroid in epidural steroid injection for lumbar radicular pain. Singapore Med. J. 48(3), 241–245 (2007).
    • 144 Kang SS, Hwang BM, Son HJ et al. The dosages of corticosteroid in transforaminal epidural steroid injections for lumbar radicular pain due to a herniated disc. Pain Physician 14(4), 361–370 (2011).•• Triamcinolone 10 mg was found to be the minimum effective dose for transforaminal epidural steroid injection in this randomized clinical trial.
    • 145 Whynes DK, McCahon RA, Ravenscroft A, Hardman J. Cost effectiveness of epidural steroid injections to manage chronic lower back pain. BMC Anesthesiol. 12, 26 (2012).
    • 146 Bicket MC, Gupta A, Brown CH, Cohen SP. Epidural injections for spinal pain: a systematic review and meta-analysis evaluating the “control” injections in randomized controlled trials. Anesthesiology 119(4), 907–931 (2013).
    • 147 Chang-Chien GC, Knezevic NN, McCormick Z, Chu SK, Trescot AM, Candido KD. Transforaminal versus interlaminar approaches to epidural steroid injections: a systematic review of comparative studies for lumbosacral radicular pain. Pain Physician 17(4), E509–E524 (2014).
    • 148 Weingart SN, Callanan LD, Ship AN et al. A physician-based voluntary reporting system for adverse events and medical errors. J. Gen. Intern. Med. 16(12), 809–814 (2001).
    • 149 Peterfreund RA, Driscoll WD, Walsh JL et al. Evaluation of a mandatory quality assurance data capture in anesthesia: a secure electronic system to capture quality assurance information linked to an automated anesthesia record. Anesth. Analg. 112(5), 1218–1225 (2011).